|

Hypertonic Lactate After Cardiac Arrest

RECRUITINGPhase 2Sponsored by Erasme University Hospital
Actively Recruiting
PhasePhase 2
SponsorErasme University Hospital
Started2025-02-19
Est. completion2027-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05004610

Summary

The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age \> 18 years old
* Sustained (\> 20 minutes) return of spontaneous circulation (ROSC)
* Comatose (GCS \< 9)
* Time to ROSC \> 15'

Exclusion Criteria:

* Protected categories (Pregnant women)
* Anticipated withdrawal of support within 24 hours
* Traumatic cause of cardiac arrest
* Body weight at admission \> 120Kg

Conditions4

Anoxic Brain InjuryCardiac ArrestHeart DiseaseIschemia-Reperfusion Injury

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.